Branch duct type intraductal papillary mucinous neoplasms
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient with suspected branch type IPMN on MRCP and CT 2. Patients with written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severely impaired organ function. 2. Patients with bleeding tendency (Plt < 50000, PT INR >= 1.5). 3. Patients with renal dysfunction (Cre >= 2.0). 4. Patient with allergy for contrast medium. 5. Patient who cant undergo MRCP because of metal inplant. 6. Patients with pregnancy. 7. Patients with malignant lesion in other organs. 8. Patients with active infection. 9. Patients with PS 4. 10. Patients with consciousness disorder. 11. Patients considered ineligible for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Adequate sample collecion rate | — |
Secondary
| Measure | Time frame |
|---|---|
| 2. Comparision of hisitopathological findings and immunohistochemical profile between EUS-FNA specimen and surgically resected specimen in patients with surgical resection. 3. Extraction of predictive factors about tumor progression in patients with diagnosed as benign IPMN and managed by observation. 4. Cyst fluid analysis using proteomics | — |
Countries
Japan
Contacts
Sapporo Medical University Fourth Department of Internal Medicine